Apollo Hospitals Enterprise Ltd., a leader in healthcare services in India, is scheduled to release its fourth-quarter results on May 30, 2024. Investors and stakeholders are keenly anticipating these results to gauge the company’s performance and strategic direction amid an evolving healthcare landscape.
Apollo Hospitals – Company Overview
Founded in 1979 by Dr. Prathap C Reddy, Apollo Hospitals has grown from a single hospital to an extensive network encompassing hospitals, diagnostic centers, and pharmacies. Based in Chennai, the company operates through its primary segments: Healthcare, Pharmacy Distribution, Clinics, and Others.
Financial Performance
Apollo Hospitals has shown a robust trend in its financial performance over the years. For the fiscal year 2023, the company reported net sales of ₹166.125 billion, a noticeable increase from the previous year’s ₹146.626 billion. The forecast for 2024 estimates net sales to rise to ₹190.532 billion. EBITDA and EBIT figures also reflect a healthy financial position, with expected improvements in 2024 suggesting a continued positive trajectory.
Stock and Market Valuation
Currently, Apollo Hospitals boasts a market capitalization of ₹841.219 billion, supported by a total of 143.785 million shares outstanding. The stock has a high price-to-earnings ratio (TTM) of 106.5433, which could indicate a premium valuation given the company’s growth prospects and dominant market position. The price to revenue (TTM) and price to book ratios stand at 4.5661 and 13.5697, respectively, reflecting strong investor confidence.
Despite the high valuation metrics, Apollo Hospitals shows a stable investment profile with a 1-year beta of 0.7903, suggesting less volatility compared to the broader market. The stock has experienced a 52-week range between ₹4410.2500 and ₹6874.4502, indicating significant investor interest and market activity.
Dividends and Returns
Apollo Hospitals has maintained a favorable dividend policy, with dividends per share for the fiscal year amounting to ₹15.00. The dividend yield forward stands at 0.2564, appealing to dividend-seeking investors.
Outlook and Expectations
As Apollo Hospitals prepares to announce its Q4 results, investors will be closely monitoring key metrics such as EBITDA, net income, and earnings per share (EPS). Analysts forecast an EPS of ₹65.6 for 2024, up from the last year’s ₹57.0. The growth in EPS is a positive sign for investors, reflecting potential profitability and efficient management execution.
Stay tuned for the Q4 earnings announcement on May 30, 2024, which will provide further insights into Apollo Hospitals’ financial health and strategic direction in the competitive healthcare market.
Join TISHHA
Going to be rocket 🚀